Planet 13 Holdings (PLNH) Accumulated Expenses (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Accumulated Expenses of $3.3 million for Q1 2026, down 55.78% year-over-year from $7.4 million in Q1 2025, and down 29.62% quarter-over-quarter from $4.6 million in Q4 2025.
Planet 13 Holdings (PLNH) Accumulated Expenses (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Accumulated Expenses for 6 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 55.78% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (down 55.78% YoY), while the FY2025 annual figure was $4.6 million, down 36.42% from the prior year.
- Accumulated Expenses fell to $3.3 million in Q1 2026 per PLNH's latest filing, from $4.6 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $10.6 million in Q3 2024 and bottomed at $3.3 million in Q1 2026.
- Historically, Accumulated Expenses has averaged $6.8 million across 5 years, with a median of $7.0 million in 2023.
- Annual changes were most pronounced in 2024 — Accumulated Expenses jumped 67.06% — and 2026, when it slumped 55.78%.
- Planet 13 Holdings' Accumulated Expenses stood at $8.1 million in 2022, then declined by 24.46% to $6.1 million in 2023, then gained by 19.48% to $7.3 million in 2024, then plunged by 36.42% to $4.6 million in 2025, then slipped by 29.62% to $3.3 million in 2026.
- Business Quant data shows PLNH's Accumulated Expenses at $3.3 million in Q1 2026, $4.6 million in Q4 2025, and $7.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.40 Mn |
| Mar 31, 2026 | 3.26 Mn |
| Dec 31, 2025 | 4.63 Mn |
| Sep 30, 2025 | 7.28 Mn |
| Jun 30, 2025 | 7.69 Mn |
| Mar 31, 2025 | 7.37 Mn |
| Dec 31, 2024 | 7.29 Mn |
| Sep 30, 2024 | 10.55 Mn |
| Jun 30, 2024 | 8.91 Mn |
| Mar 31, 2024 | 5.19 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 6.32 Mn |
| Jun 30, 2023 | 6.99 Mn |
| Mar 31, 2023 | 6.54 Mn |
| Dec 31, 2022 | 8.07 Mn |
| Sep 30, 2022 | 5.99 Mn |
| Dec 31, 2021 | 7.03 Mn |